Effects of desloratadine, diphenhydramine, and placebo on driving performance and psychomotor performance measurements
- 28 May 2004
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in European Journal of Clinical Pharmacology
- Vol. 60 (5), 307-313
- https://doi.org/10.1007/s00228-004-0757-9
Abstract
First-generation antihistamines taken for relief of allergic rhinitis are sedating and pose potential risks for those driving a car or operating machinery. Desloratadine is a potent, selective, histamine H1-receptor antagonist that does not easily cross the blood–brain barrier. It is nonsedating at therapeutic doses and should not affect driving or psychomotor performance. This study compared the acute effects of desloratadine with diphenhydramine (active control) and placebo on the performance of healthy subjects evaluated with standard over-the-road driving tests (primary objective). The subjects’ performances were also evaluated (secondary objective) with the use of conventional performance tests. Eighteen men and women received a single dose of desloratadine 5 mg, diphenhydramine 50 mg, or placebo during each period of this randomized, double-blind, three-way, crossover study. Two hours post-dosing, subjects operated a specially instrumented vehicle in a 90-min test designed to measure their ability (1) to maintain constant speed and lateral position while following another vehicle at a constant distance and (2) to respond to brake signals. Additionally, a full battery of performance tests was administered. No significant differences were noted between desloratadine and placebo in standard deviation of lateral position (SDLP), whereas diphenhydramine treatment significantly increased SDLP (P P P=0.033). No differences were seen among treatments in deviation of speed or distance to the lead car. The majority of performance tests showed no significant differences among groups. Desloratadine at a therapeutic dose does not impair driving performance.Keywords
This publication has 22 references indexed in Scilit:
- Decrements in vigilance and cognitive functioning associated with ragweed-induced allergic rhinitisAnnals of Allergy, Asthma & Immunology, 2002
- Desloratadine Demonstrates Dose Proportionality in Healthy Adults After Single DosesClinical Pharmacokinetics, 2002
- Clinical Pharmacology of New Histamiine H1 Receptor AntagonistsClinical Pharmacokinetics, 1999
- Fexofenadine's effects, alone and with alcohol, on actual driving and psychomotor performanceJournal of Allergy and Clinical Immunology, 1998
- Effects of mefloquine alone and with alcohol on psychomotor and driving performanceEuropean Journal of Clinical Pharmacology, 1996
- Specific review of the psychometric effects of cetirizineAllergy, 1995
- Antihistamine effects on actual driving performance in a standard test: a summary of Dutch experience, 1989‐94Allergy, 1995
- Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance.British Journal of Clinical Pharmacology, 1993
- Effects of loratadine and cetirizine on actual driving and psychometric test performance, and EEG during drivingEuropean Journal of Clinical Pharmacology, 1992
- Quantification of Sleepiness: A New ApproachPsychophysiology, 1973